{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:34:28Z","timestamp":1790768068003,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2012CB724003"],"award-info":[{"award-number":["2012CB724003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.lfs.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T01:19:38Z","timestamp":1422580778000},"page":"136-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres"],"prefix":"10.1016","volume":"124","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.01.014_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1\u03b2 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.lfs.2015.01.014_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.lfs.2015.01.014_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.lfs.2015.01.014_bb0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroscience.2004.10.026","article-title":"Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA treated dyskinetic monkeys","volume":"132","author":"Chen","year":"2005","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.lfs.2015.01.014_bb0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.neuropharm.2011.01.043","article-title":"Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation","volume":"60","author":"Chung","year":"2011","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.lfs.2015.01.014_bb0045","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2015.01.014_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","article-title":"Metabolism and functions of glutathione in brain","volume":"62","author":"Dringen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.lfs.2015.01.014_bb0060","first-page":"412","article-title":"Biology of disease: free radicals and tissue injury","volume":"47","author":"Freeman","year":"1982","journal-title":"Lab. Investig."},{"issue":"18","key":"10.1016\/j.lfs.2015.01.014_bb0065","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson's disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"30","key":"10.1016\/j.lfs.2015.01.014_bb0070","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2015.01.014_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson's disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2015.01.014_bb0095","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1 Suppl. 1","key":"10.1016\/j.lfs.2015.01.014_bb0100","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1212\/WNL.62.1_suppl_1.S47","article-title":"Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulation","volume":"62","author":"Jenner","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lfs.2015.01.014_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbr.2008.06.021","article-title":"Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of Parkinsonism","volume":"194","author":"Larramendy","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.lfs.2015.01.014_bb0120","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jep.2011.12.015","article-title":"Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions","volume":"139","author":"Lee","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2015.01.014_bb0125","series-title":"Rotigotine pharmacology\/toxicology","author":"Freed","year":"2006"},{"issue":"1","key":"10.1016\/j.lfs.2015.01.014_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molbrainres.2004.09.014","article-title":"Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?","volume":"134","author":"Maguire-Zeiss","year":"2005","journal-title":"Mol. Brain Res."},{"issue":"2","key":"10.1016\/j.lfs.2015.01.014_bb0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1\u03b2, interleukin-6, epidermal growth factor and transforming growth factor-\u03b1 are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2015.01.014_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6 and transforming growth factor-\u03b1 levels are elevated in ventricular cerebrospinal fluid in juvenile Parkinsonism and Parkinson's disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2015.01.014_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2015.01.014_bb0155","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-009-9037-x","article-title":"Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation","volume":"15","author":"Moon","year":"2009","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.lfs.2015.01.014_bb0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.WNL.0000149637.70961.4C","article-title":"Duodenal levodopa infusion monotherapy vs. oral polypharmacy in advanced Parkinson disease","volume":"64","author":"Nyholm","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lfs.2015.01.014_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.med.55.091902.104422","article-title":"The scientific basis for the current treatment of Parkinson's disease","volume":"55","author":"Olanow","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2015.01.014_bb0170","doi-asserted-by":"crossref","first-page":"19126","DOI":"10.1073\/pnas.0508215102","volume":"102","author":"Perier","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2015.01.014_bb0175","doi-asserted-by":"crossref","first-page":"401264","DOI":"10.1155\/2012\/401264","article-title":"Oxidative stress and microglial cells in Parkinson's disease","volume":"2012","author":"Peterson","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.lfs.2015.01.014_bb0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.10031","article-title":"Clinical-pathological study of levodopa complications","volume":"17","author":"Rajput","year":"2002","journal-title":"Mov. Disord."},{"issue":"20","key":"10.1016\/j.lfs.2015.01.014_bb0185","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lfs.2015.01.014_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson's disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.lfs.2015.01.014_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2478\/s11658-007-0015-0","article-title":"The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables","volume":"12","author":"Sankar","year":"2007","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2015.01.014_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2007.12.001","article-title":"Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease","volume":"432","author":"Scheller","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2015.01.014_bb0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1468-1331.2007.01674.x","article-title":"Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease","volume":"15","author":"Steiger","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.lfs.2015.01.014_bb0215","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s11095-012-0762-0","article-title":"Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats","volume":"29","author":"Wang","year":"2012","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.lfs.2015.01.014_bb0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF01181319","article-title":"Thirty years of synaptosome research","volume":"22","author":"Whittaker","year":"1993","journal-title":"J. Neurocytol."},{"issue":"3","key":"10.1016\/j.lfs.2015.01.014_bb9000","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.lfs.2015.01.014_bb9800","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"28","key":"10.1016\/j.lfs.2015.01.014_bb9700","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0970-05.2005","article-title":"Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson\u2019s disease in mice","volume":"25","author":"Choi","year":"2005","journal-title":"J. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.lfs.2015.01.014_bb9600","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2008.10.005","article-title":"Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson\u2019s disease in rats","volume":"600","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2015.01.014_bb9500","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/S1353-8020(11)70057-8","article-title":"Animal models of Parkinson\u2019s disease","volume":"18","author":"Jackson-Lewis","year":"2012","journal-title":"Parkinsonism. Relat. Disord."},{"issue":"10","key":"10.1016\/j.lfs.2015.01.014_bb9400","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci U S A."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T22:24:44Z","timestamp":1717712684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"alternative-id":["S0024320515000545"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.01.014","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}